Scripta Therapeutics Ltd

About Scripta Therapeutics Ltd

Scripta Therapeutics Ltd is a pioneering biotechnology company based in the UK, dedicated to transforming the landscape of therapeutic development through innovative RNA-based technologies. Our mission is to harness the power of synthetic biology to create novel treatments for a range of diseases, including genetic disorders and cancers.

At Scripta Therapeutics, we focus on the design and synthesis of RNA molecules that can modulate gene expression with high precision. Our proprietary platform enables us to develop therapies that are not only effective but also safe, minimising side effects commonly associated with traditional treatments.

We believe in collaboration and actively seek partnerships with academic institutions and pharmaceutical companies to accelerate our research and development efforts. Our team comprises leading scientists and industry experts who are passionate about advancing healthcare through cutting-edge science.

Our core activities include:

• Research and Development: Conducting extensive research to discover and develop RNA-based therapeutics.
• Clinical Trials: Initiating and managing clinical trials to evaluate the safety and efficacy of our products.
• Regulatory Affairs: Navigating the complex regulatory landscape to ensure compliance and facilitate product approvals.

As we look to the future, Scripta Therapeutics aims to expand its portfolio of therapies and continue making significant contributions to the field of medicine. We are committed to improving patient outcomes and providing hope to those affected by serious health conditions.